Primary Gastric Lymphoma (Diffuse Large B Cell Type)
Milind Pandey, Sunita Vagha, Raunak Kotecha, Anchal Manchanda
Journal of Pharmaceutical Research International · pp. 54–57 · Published 13 Jul 2021
10.9734/jpri/2021/v33i37A31979Abstract
The most frequent extra-nodal site of lymphoma is gastric lymphoma. The bulk of such lesions are extra nodal marginal zone B mucosal cell lymphoma correlated with lymphoid tissue (MALT) type or diffuse lymphoma of large B cells. We are reporting a case of diffuse major B-Cellular gastric lymphoma, which at first showed indigestion, abdominal heaviness, nausea and widespread weakness with 3-4 months of weight loss. In the antropyloric region and distal portion of lesser curvature of stomach suggestive of aetiology of cancer, the CT abdomen shows circumferential wall thickening. DLBCL has been confirmed by HPE and IHC. The neoplasm entered serosa and was found to have adherence to the pancreatic capsule in stage IIE of gastric lymphoma. Following the staging, treatment with an R-CHOP regimen (rituximab, cyclophosphamide, oncovin (vincristine), hydroxydaunorubicin, and prednisone) was done.
Cited by 22
Abhishek Gujar, Mitushi Deshmukh · Journal of Pharmaceutical Negative Results · 2022
Grisha Rajesh Ratnani, Vishnu Vardhan · Journal of Pharmaceutical Negative Results · 2022
Sagarika Ghangale, Mitushi Deshmukh · Journal of Pharmaceutical Negative Results · 2022
Shruti S Bhoge, Mitushi Deshmukh, Vaishnavi M Thakre · Journal of Pharmaceutical Negative Results · 2022
Juhi pattiwar, R. Walke · Journal of Pharmaceutical Negative Results · 2022
Muskan.K. Bhatiya, R. Walke · Journal of Pharmaceutical Negative Results · 2022
Neha Arya, Mitushi Deshmukh · Journal of Pharmaceutical Negative Results · 2022
Rushali Jaiswal, Mitushi P. Deshmukh · Journal of Pharmaceutical Negative Results · 2022
Shardul Timande, Shalini Moon, Archana Teltumbde · Journal of Pharmaceutical Negative Results · 2022
Namrata Agase, Ruchira Ankar, Tejaswee Lohakare · Journal of Pharmaceutical Negative Results · 2022
Related research
- Non Hodgkin Lymphoma and Related Factors in Patients with Peripheral Lymphadenopathy in Lubumbashi (DR Congo) — shares topic coverage
- Oral Busulfan and Cyclophosphamide (BU/CY) versus Cyclophosphamide, Melphalan and Vepsid (Etoposide) (CMV) with Autologous Stem Cell Transplant in Patients with Relapsed Non-Hodgkin Lymphomas (NHL) — shares topic coverage
- Circulating Angiogenesis Factors in Patients with Non-Hodgkin’s Lymphoma — shares topic coverage
Article metrics
Real usage data collected on this platform.
28
Page views
0
PDF downloads
0
Outbound clicks
22
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.